Effects of resveratrol on cognitive performance, mood and cerebrovascular function in post-menopausal women; a 14-week randomised placebo-controlled intervention trial

Nutrients

Volumn 9, Issue 1, 2017, Pages

  Evans, Hamish M ^a   Howe, Peter R C ^a   Wong, Rachel H X ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Cerebrovascular function; Cognitive decline; Menopause; Resveratrol

Indexed keywords

PLACEBO; RESVERATROL; PHYTOESTROGEN; STILBENE DERIVATIVE;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BRAIN BLOOD FLOW; DOPPLER FLOWMETRY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; HYPERCAPNIA; INTERVENTION STUDY; MALE; MIDDLE CEREBRAL ARTERY; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; MOOD; NEUROVASCULAR COUPLING; POST HOC ANALYSIS; POSTMENOPAUSE; PULSATILITY INDEX; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REY AUDITORY VERBAL LEARNING TEST; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; VERBAL MEMORY; WAIST CIRCUMFERENCE; AFFECT; BLOOD; BRAIN CIRCULATION; COGNITION; CONTROLLED STUDY; DIETARY SUPPLEMENT; DRUG EFFECTS; MIDDLE AGED; VERY ELDERLY;

AFFECT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR CIRCULATION; COGNITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIDDLE AGED; PHYTOESTROGENS; POSTMENOPAUSE; STILBENES; SURVEYS AND QUESTIONNAIRES;

EID: 85009062768     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9010027     Document Type: Article

References (42)

1. Prince, M.; Wimo, A.; Geurchet, M.; Ali, G.; Wu, Y.; Prina, M. The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends; Alzhiemer’s Disease International: London, UK, 2015.
2. Li, R.; Cui, J.; Shen, Y. Brain sex matters: Estrogen in cognition and Alzheimer’s disease. Mol. Cell. Endocrinol. 2014, 389, 13–21.
3. Ryan, J.; Stanczyk, F.Z.; Dennerstein, L.; Mack, W.J.; Clark, M.S.; Szoeke, C.; Henderson, V.W. Executive functions in recently post-menopausal women: Absence of strong association with serum gonadal steroids. Brain Res. 2011, 1379, 199–205.
4. Craig, M.C.; Brammer, M.; Maki, P.M.; Fletcher, P.C.; Daly, E.M.; Rymer, J.; Giampietro, V.; Picchioni, M.; Stahl, D.; Murphy, D.G.M. The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women. Psychoneuroendocrinology 2010, 35, 987–1000.
5. Silvestrini, M.; Pasqualetti, P.; Baruffaldi, R.; Bartolini, M.; Handouk, Y.; Matteis, M.; Moffa, F.; Provinciali, L.; Vernieri, F. Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 2006, 37, 1010–1015.
6. Sun, Z.W.; Zhu, Y.X.; Liu, H.Y.; Liu, J.; Zhu, X.Q.; Zhou, J.N.; Liu, R.Y. Decreased cerebral blood flow velocity in apolipoprotein E epsilon4 allele carriers with mild cognitive impairment. Eur. J. Neurol. 2007, 14, 150–155.
7. Matteis, M.; Troisi, E.; Monaldo, B.C.; Caltagirone, C.; Silvestrini, M. Age and sex differences in cerebral hemodynamics: A transcranial Doppler study. Stroke 1998, 29, 963–967.
8. Bromberger, J.T.; Kravitz, H.M.; Chang, Y.F.; Cyranowski, J.M.; Brown, C.; Matthews, K.A. Major depression during and after the menopausal transition: Study of Women’s Health across the Nation (SWAN). Psychol. Med. 2011, 41, 1879–1888.
9. Neu, P.; Schlattmann, P.; Schilling, A.; Hartmann, A. Cerebrovascular reactivity in major depression: A pilot study. Psychosom. Med. 2004, 66, 6–8.
10. Weber, M.T.; Maki, P.M.; McDermott, M.P. Cognition and mood in perimenopause: A systematic review and meta-analysis. J. Steroid Biochem. Mol. Biol. 2014, 142, 90–98.
11. Wong, R.H.X.; Evans, H.M.; Howe, P.R.C. Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women. Alzheimer’s Dement. Transl. Res. Clin. Interv. 2016, 2, 162–168.
12. Xia, N.; Forstermann, U.; Li, H. Resveratrol and endothelial nitric oxide. Molecules 2014, 19, 16102–16121.
13. Kodali, M.; Parihar, V.K.; Hattiangady, B.; Mishra, V.; Shuai, B.; Shetty, A.K. Resveratrol prevents age-related memory and mood dysfunction with increased hippocampal neurogenesis and microvasculature, and reduced glial activation. Sci. Rep. 2015, 5, 8075.
14. Schmatz, R.; Mazzanti, C.M.; Spanevello, R.; Stefanello, N.; Gutierres, J.; Correa, M.; da Rosa, M.M.; Rubin, M.A.; Chitolina Schetinger, M.R.; Morsch, V.M. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur. J. Pharmacol. 2009, 610, 42–48.
15. Dal-Pan, A.; Pifferi, F.; Marchal, J.; Picq, J.L.; Aujarda, F.; Consortium R. Cognitive performances are selectively enhanced during chronic caloric restriction or resveratrol supplementation in a primate. PLoS ONE 2011, 6, e16581.
16. Witte, A.V.; Kerti, L.; Margulies, D.S.; Floel, A. Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J. Neurosci. 2014, 34, 7862–7870.
17. Kennedy, D.O.; Wightman, E.L.; Reay, J.L.; Lietz, G.; Okello, E.J.; Wilde, A.; Haskell, C.F. Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: A double-blind, placebo-controlled, crossover investigation. Am. J. Clin. Nutr. 2010, 91, 1590–1597.
18. Wightman, E.L.; Reay, J.L.; Haskell, C.F.; Williamson, G.; Dew, T.P.; Kennedy, D.O. Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: A randomised, double-blind, placebo-controlled, cross-over investigation. Br. J. Nutr. 2014, 112, 203–213.
19. Wong, R.H.; Nealon, R.S.; Scholey, A.; Howe, P.R. Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus. Nutr. Metab. Cardiovasc. Dis. 2016, 26, 393–399.
20. Kodl, C.T.; Seaquist, E.R. Cognitive dysfunction and diabetes mellitus. Endocr. Rev. 2008, 29, 494–511.
21. Wong, R.H.; Raederstorff, D.; Howe, P.R. Acute resveratrol consumption improves neurovascular coupling capacity in adults with type 2 diabetes mellitus. Nutrients 2016, 8.
22. Altman, D.G.; Bland, J.M. Treatment allocation by minimisation. BMJ 2005, 330, 843.
23. Evans, H.M.; Howe, P.R.; Wong, R.H. Clinical evaluation of effects of chronic resveratrol supplementation on cerebrovascular function, cognition, mood, physical function and general well-being in post-menopausal women-rationale and study design. Nutrients 2016, 8, 150.
24. Bravo, G.; Hebert, R. Age-and education-specific reference values for the Mini-Mental and modified Mini-Mental State Examinations derived from a non-demented elderly population. Int. J. Geriatr. Psychiatry 1997, 12, 1008–1018.
25. Schmidt, M. Rey Auditory and Verbal Learning Test: A Handbook; Western Psychological Services: Los Angeles, CA, USA, 1996.
26. Adlam, A.L.; Patterson, K.; Bozeat, S.; Hodges, J.R. The Cambridge semantic memory test battery: Detection of semantic deficits in semantic dementia and Alzheimer’s disease. Neurocase 2010, 16, 193–207.
27. Lovato, N.; Lack, L.; Wright, H.; Kemps, E.; Cant, M.; Humphreys, J. A preliminary assessment of the reliability and validity of a computerized working memory task. Percept. Mot. Skills 2013, 116, 368–381.
28. Sanchez-Cubillo, I.; Perianez, J.A.; Adrover-Roig, D.; Rodriguez-Sanchez, J.M.; Rios-Lago, M.; Tirapu, J.; Barceló, F. Construct validity of the Trail Making Test: Role of task-switching, working memory, inhibition/interference control, and visuomotor abilities. J. Int. Neuropsychol. Soc. 2009, 15, 438–450.
29. Nunes, T.; Almeida, L.; Rocha, J.F.; Falcao, A.; Fernandes-Lopes, C.; Loureiro, A.I.; Wright, L.; Vaz-da-Silva, M.; Soares-da-Silva, P. Pharmacokinetics of trans-resveratrol following repeated administration in healthy elderly and young subjects. J. Clin. Pharmacol. 2009, 49, 1477–1482.
30. Obrist, W.D. Electroencephalographic Changes in Normal Aging and Dementia. In Brain Function in Old Age; Hoffmeister, F., Müller, C., Eds.; Springer: Berlin/Heidelberg, Germany, 1979; pp. 102–111.
31. Ruitenberg, A.; den Heijer, T.; Bakker, S.L.; van Swieten, J.C.; Koudstaal, P.J.; Hofman, A.; Breteler, M.M. Cerebral hypoperfusion and clinical onset of dementia: The Rotterdam Study. Ann. Neurol. 2005, 57, 789–794.
32. Lee, S.T.; Jung, K.H.; Lee, Y.S. Decreased vasomotor reactivity in Alzheimer’s disease. J. Clin. Neurol. 2007, 3, 18–23.
33. Stefani, A.; Sancesario, G.; Pierantozzi, M.; Leone, G.; Galati, S.; Hainsworth, A.H.; Diomedi, M. CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer’s and mixed dementia. J. Neurol. Sci. 2009, 283, 109–115.
34. Sackeim, H.A.; Prohovnik, I.; Moeller, J.R.; Mayeux, R.; Stern, Y.; Devanand, D.P. Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer’s disease. J. Nucl. Med. 1993, 34, 1090–1101.
35. Reinhard, M.; Schwarzer, G.; Briel, M.; Altamura, C.; Palazzo, P.; King, A.; Bornstein, N.M.; Petersen, N.; Motschall, E.; Hetzel, A.; et al. Cerebrovascular reactivity predicts stroke in high-grade carotid artery disease. Neurology 2014, 83, 1424–1431.
36. Cantin, S.; Villien, M.; Moreaud, O.; Tropres, I.; Keignart, S.; Chipon, E.; Le Bas, J.F.; Warnking, J.; Krainik, A. Impaired cerebral vasoreactivity to CO2 in Alzheimer’s disease using BOLD fMRI. Neuroimage 2011, 58, 579–587.
37. Wang, Q.; Xu, J.; Rottinghaus, G.E.; Simonyi, A.; Lubahn, D.; Sun, G.Y.; Sun, A.Y. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 2002, 958, 439–447.
38. Wang, Q.; Yu, S.; Simonyi, A.; Rottinghaus, G.; Sun, G.Y.; Sun, A.Y. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem. Res. 2004, 29, 2105–2112.
39. Wang, W.-Y.; Tan, M.-S.; Yu, J.-T.; Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann. Transl. Med. 2015, 3, 136.
40. Xia, S.; Zhang, X.; Zheng, S.; Khanabdali, R.; Kalionis, B.; Wu, J.; Wan, W.; Tai, X. An Update on inflamm-aging: Mechanisms, prevention, and treatment. J. Immunol. Res. 2016, 2016, 8426874.
41. Woolley, C.S.; McEwen, B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J. Neurosci. 1992, 12, 2549–2554.
42. Gazzaley, A.H.; Weiland, N.G.; McEwen, B.S.; Morrison, J.H. Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 1996, 16, 6830–6838.